Clinical Trials
7 trialsNCT06184867 2026-03-06
CATALYST
Rutgers, The State University of New Jersey
Phase NA Completed
NCT00146562 2023-08-02
Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00544232 2016-02-15
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
GBG Forschungs GmbH
Phase 3 Completed
NCT00261313 2010-02-26
ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast Cancer
Amgen
Phase 2 Completed
NCT00036023 2009-05-11
Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies
Amgen
Phase 2 Completed
NCT00309920 2009-02-09
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00120692 2007-12-24
Treatment for Patients Suffering From Anemia Due to Chemotherapy
Amgen
Phase 2 Completed